Ondine Biomedical Inc. 25 November 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN CA68234M2058 Issuer...
Ondine Biomedical Inc. 22 November 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN CA68234M2058 Issuer...
Ondine Biomedical Inc. 22 November 2024 ONDINE BIOMEDICAL INC. ("Ondine Biomedical", "Ondine", or the "Company") Director Holdings ...
Ondine Biomedical Inc. 18 November 2024 Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the...
Ondine Biomedical Inc. 15 November 2024 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION...
Ondine Biomedical Inc. 14 November 2024 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION...
Ondine Biomedical Inc. 11 November 2024 ONDINE BIOMEDICAL INC. ("Ondine Biomedical", "Ondine", or the "Company") Update on Private Placement...
Ondine Biomedical Inc. 01 November 2024 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION...
Ondine Biomedical Inc on Friday revealed a proposed fundraise as it looks to fund a phase 3 clinical study in the US. ...
Ondine Biomedical Inc. 01 November 2024 THIS ANNOUNCEMENT (INCLUDING THE APPENDICES) AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS...
Ondine Biomedical Inc. 30 October 2024 This Announcement contains inside information for the purposes of Article 7 of the Market Abuse...
Ondine Biomedical Inc. 28 October 2024 ONDINE BIOMEDICAL INC. ("Ondine Biomedical", "Ondine" or the "Company") Ondine continues commercial...
Inc - Vancouver-based company specialising in photodisinfection-based therapies - Announces King's College Hospital i ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.